Joseph T. Rabban

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

Laura J. Esserman, Donald A. Berry, Angela DeMichele et al. · Journal of Clinical Oncology · 2012 · 441 citations · Full text

Medicine, Biostatistics, Oncology +11

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Laura J. Esserman, Donald A. Berry, Maggie C.U. Cheang et al. · Breast Cancer Research and Treatment · 2011 · 376 citations · Full text

Medicine, Biostatistics, Oncology +17

Dual loss of the <scp>SWI</scp>/<scp>SNF</scp> complex <scp>ATPases SMARCA4</scp>/<scp>BRG1</scp> and <scp>SMARCA2</scp>/<scp>BRM</scp> is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

Anthony N. Karnezis, Yemin Wang, Pilar Ramos et al. · The Journal of Pathology · 2015 · 225 citations · Full text

Medicine, Molecular Biology, Oncology +10

Abrogated Response to Cellular Stress Identifies DCIS Associated with Subsequent Tumor Events and Defines Basal-like Breast Tumors

Mona L. Gauthier, Hal K. Berman, Caroline Miller et al. · Cancer Cell · 2007 · 217 citations · Full text

Medicine, Cancer Biology, Oncology +15

CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues

Rosa Anna DeFilippis, Hang Chang, Nancy Dumont et al. · Cancer Discovery · 2012 · 211 citations

Medicine, Cell Biology, Oncology +17